These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 1269514
21. Stool chymotrypsin activity measured by a spectrophotometric procedure to identify pancreatic disease in infants. Remtulla MA, Durie PR, Goldberg DM. Clin Biochem; 1986 Dec; 19(6):341-7. PubMed ID: 3581468 [Abstract] [Full Text] [Related]
22. Usefulness of random fecal alpha 1-antitrypsin and chymotrypsin determinations in children. Mbonda E, Forget P, Saye Z, Leclercq-Foucart J. J Pediatr Gastroenterol Nutr; 1989 Jan; 8(1):85-8. PubMed ID: 2786561 [Abstract] [Full Text] [Related]
23. Fecal chymotrypsin levels in children with pancreatic insufficiency. de Pedro C, Codoceo R, Vazquez P, Hernanz A. Clin Biochem; 1986 Dec; 19(6):338-40. PubMed ID: 3581467 [Abstract] [Full Text] [Related]
24. Sensitivity assessment of chymotrypsin faecal test in controlling malabsorption in cystic fibrosis. Santini B, Lerro P, Ciervo T, Robazza PV, Ansaldi N. Acta Univ Carol Med (Praha); 1990 Dec; 36(1-4):165-8. PubMed ID: 2130685 [No Abstract] [Full Text] [Related]
25. Faecal chymotrypsin concentrations in neonates with cystic fibrosis and healthy controls. Brown GA, Halliday RB, Turner PJ, Smalley CA. Arch Dis Child; 1988 Oct; 63(10):1229-33. PubMed ID: 3196049 [Abstract] [Full Text] [Related]
30. QUANTITATIVE DETERMINATION OF FECAL CHYMOTRYPSIN AS A SCREENING TEST FOR PANCREATIC EXOCRINE INSUFFICIENCY. DYCK W, AMMANN R. Am J Dig Dis; 1965 Jun; 10():530-44. PubMed ID: 14295484 [No Abstract] [Full Text] [Related]
32. Comparison of the diagnostic value of serum pancreatic isoamylase and immunoreactive trypsin measurement in patients with cystic fibrosis. Brown RC, Chalmers DM, Rowe VL, Kelleher J, Littlewood JM, Losowsky MS. J Clin Pathol; 1982 May; 35(5):547-9. PubMed ID: 7085899 [Abstract] [Full Text] [Related]
33. [Fatty acid composition of fecal lipids in children with cystic fibrosis before and during pancreatin therapy]. Cardi E, Antonelli M, Annibaldi L. Minerva Pediatr; 1967 Nov 10; 19(45):2011-3. PubMed ID: 5616201 [No Abstract] [Full Text] [Related]
34. The steatocrit: a simple method for monitoring fat malabsorption in patients with cystic fibrosis. Colombo C, Maiavacca R, Ronchi M, Consalvo E, Amoretti M, Giunta A. J Pediatr Gastroenterol Nutr; 1987 Nov 10; 6(6):926-30. PubMed ID: 3681578 [Abstract] [Full Text] [Related]
35. Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis. Lapey A, Kattwinkel J, Di Sant'Agnese PA, Laster L. J Pediatr; 1974 Mar 10; 84(3):328-34. PubMed ID: 4811984 [No Abstract] [Full Text] [Related]
39. Stool elastase as a diagnostic test for pancreatic function in children with cystic fibrosis. Wallis C, Leung T, Cubitt D, Reynolds A. Lancet; 1997 Oct 04; 350(9083):1001. PubMed ID: 9329517 [No Abstract] [Full Text] [Related]